Public attitudes toward the treatment of nicotine addiction

Nicotine and Tobacco Research

Volumn 15, Issue 9, 2013, Pages 1617-1622

  Morphett, Kylie ^a   Lucke, Jayne ^a   Gartner, Coral ^a   Carter, Adrian ^a   Meurk, Carla ^a   Hall, Wayne ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE PATCH;

ADULT; ANALYTIC METHOD; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HEALTH BELIEF; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PHYSICIAN; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW; SMOKING CESSATION; TOBACCO DEPENDENCE;

EID: 84880407303     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntt037     Document Type: Article

References (35)

1. Alpert, H. R., Connolly, G. N., & Biener, L. (2012). A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tobacco Control. doi:10.1136/tobaccocontrol-2011-050129
2. Australian Institute of Health and Welfare. (2011). 2010 National Drug Strategy Household Survey report. Drug Statistics Series. Canberra: AIHW.
3. Ballard, K., & Elston, M. A. (2005). Medicalisation: A multidimensional concept. Social Theory & Health, 3, 228-241. doi:10.1057/palgrave.sth.8700053
4. Balmford, J., & Borland, R. (2008). What does it mean to want to quit? Drug and Alcohol Review, 27, 21-27. doi:10.1080/09595230701710829
5. Blum, A. (1984). Nicotine chewing gum and the medicalization of smoking. Annals of Internal Medicine, 101, 121-123.
6. Cahill, K., Stead, L. F., & Lancaster, T. (2012). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, 4, CD006103. doi:10.1002/14651858. CD006103.pub6
7. Caron, L., Karkazis, K., Raffin, T. A., Swan, G., & Koenig, B. A. (2005). Nicotine addiction through a neurogenomic prism: Ethics, public health, and smoking. Nicotine & Tobacco Research, 7, 181-197. doi:10.1080/14622200500055251
8. Carter, S., Borland, R., & Chapman, S. (2001). Finding the strength to kill your best friend. Smokers talk about smoking and quitting. Sydney: Australian Smoking Cessation Consortium and GlaxoSmithKline Consumer Healthcare.
9. Chapman, S., & MacKenzie, R. (2010). The global research neglect of unassisted smoking cessation: Causes and consequences. PLOS Medicine, 7, e1000216. doi:10.1371/journal. pmed.1000216
10. Clarke, A. E., Shim, J. K., Mamo, L., Fosket, J. R., & Fishman, J. R. (2003). Biomedicalization: Technoscientific transformations of health, illness, and US biomedicine. American Sociological Review, 68, 161-194.
11. Conrad, P. (1992). Medicalization and social control. Annual Review of Sociology, 18, 209-232.
12. Cooper, J., Borland, R., & Yong, H.-H. (2011). Australian smokers increasingly use help to quit, but number of attempts remains stable: Findings from the International Tobacco Control Study 2002-09. Australian and New Zealand Journal of Public Health, 35, 368-376. doi:10.1111/j.1753-6405.2011.00733.x
13. Cunningham, J. A., Sobell, L. C., Freedman, J. L., & Sobell, M. B. (1994). Beliefs about the causes of substance abuse: A comparison of three drugs. Journal of Substance Abuse, 6, 219-226.
14. Davis, R. M. (1992). The language of nicotine addiction: Purging the word "habit" from our lexicon. Tobacco Control, 1, 163-164.
15. Dingel, M. J., Karkazis, K., & Koenig, B. A. (2011). Framing nicotine addiction as a "disease of the brain": Social and ethical consequences. [Article]. Social Science Quarterly, 92, 1363-1388. doi:10.1111/j.1540-6237.2011.00822.x
16. Eisenberg, M. J., Filion, K. B., Yavin, D., Bélisle, P., Mottillo, S., Joseph, L., . . . Pilote, L. (2008). Pharmacotherapies for smoking cessation: A meta-analysis of randomized controlled trials. Canadian Medical Association Journal, 179, 135-144. doi:10.1503/cmaj.070256
17. Etter, J. F., Burri, M., & Stapleton, J. (2007). The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: A meta-analysis. Addiction, 102, 815-822. doi:10.1111/j.1360-0443.2007.01822.x
18. Fiore, M. C., Jaen, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., Curry, S. J., . . . Wewers, M. E. (2008). Treating tobacco use and dependence: 2008 update. Rockville, MA: U.S. Department of Health and Human Services.
19. Gartner, C. E., Carter, A., & Partridge, B. (2012). What are the public policy implications of a neurobiological view of addiction?. Addiction, 107, 1199-1200. doi:10.1111/ j.1360-0443.2012.03812.x
20. Hughes, J. R. (2009). Smokers'beliefs about the inability to stop smoking. Addictive Behaviors, 34, 1005-1009. doi:10.1016/j.addbeh.2009.06.013
21. Hughes, J. R., Stead, L. F., & Lancaster, T. (2010). Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, 3, CD000031. doi:10.1002/14651858. CD000031.pub3
22. Kasza, K. A., Hyland, A. J., Borland, R., McNeill, A. D., Bansal-Travers, M., Fix, B. V., . . . Cummings, K. M. (2012). Effectiveness of stop-smoking medications: Findings from the International Tobacco Control (ITC) Four Country Survey. Addiction, doi:10.1111/j.1360-0443.2012. 04009.x
23. Kuppin, S., & Carpiano, R. M. (2006). Public conceptions of serious mental illness and substance abuse, their causes and treatments: Findings from the 1996 general social survey. American Journal of Public Health, 96, 1766-1771. doi:10.2105/ajph.2004.060855
24. Meurk, C., Carter, A., Hall, W., & Lucke, J. (2013). Public understandings of addiction: where do neurobiological explanations fit?. Neuroethics. doi:10.1007/s12152-013-9180-1
25. Moynihan, R., Heath, I., & Henry, D. (2002). Selling sickness: The pharmaceutical industry and disease mongering. BMJ, 324, 886-891. doi:10.1136/bmj.324.7342.886
26. Patten, C. A., Smith, C. M., Brockman, T. A., Decker, P. A., Hughes, C. A., Nadeau, A. M., . . . Zhu, S. H. (2011). Support-person promotion of a smoking quitline: A randomized controlled trial. American Journal of Preventive Medicine, 41, 17-23. doi:10.1016/j.amepre.2011.03.012
27. Pierce, J. P., Cummins, S. E., White, M. M., Humphrey, A., & Messer, K. (2012). Quitlines and nicotine replacement for smoking cessation: Do we need to change policy? Annual Review of Public Health, 33, 341-356. doi:10.1146/ annurev-publhealth-031811-124624
28. Popay, J., & Williams, G. (1996). Public health research and lay knowledge. Social Science & Medicine (1982), 42, 759-768.
29. QSR International Pty Ltd. (2010). NVivo 9. [Computer software]. Detail obtained from QSR website http://www. qsrinternational.com/products_nvivo.aspx. Melbourne, Australia.
30. Stead, L., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews, 1, CD000146. doi:10.1002/14651858.CD000146.pub3
31. Wakefield, M., & Durrant, R. (2006). Effects of exposure of youths at risk for smoking to television advertising for Nicotine Replacement Therapy and Zyban®: An experimental study. Health Communication, 19, 253-258. doi:10.1207/ s15327027hc1903_7
32. Walsh, R. A. (2008). Over-the-counter nicotine replacement therapy: A methodological review of the evidence supporting its effectiveness. Drug and Alcohol Review, 27, 529-547. doi:10.1080/09595230802245527
33. West, R., DiMarino, M. E., Gitchell, J., & McNeill, A. (2005). Impact of UK policy initiatives on use of medicines to aid smoking cessation. Tobacco Control, 14, 166-171. doi:10.1136/tc.2004.008649
34. Zhu, S.-H., Lee, M., Zhuang, Y.-L., Gamst, A., & Wolfson, T. (2012). Interventions to increase smoking cessation at the population level: How much progress has been made in the last two decades?. Tobacco Control, 21, 110-118. doi:10.1136/tobaccocontrol-2011-050371
35. Zwar, N., Richmond, R., Borland, R., Peters, M., Litt, J., Bell, J., . . . Ferretter, I. (2011). Supporting smoking cessation: A guide for health professionals. Melbourne: The Royal Australian College of General Practitioners.